# Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma

> **NCT00911326** · PHASE3 · TERMINATED · sponsor: **Navidea Biopharmaceuticals** · enrollment: 101 (actual)

## Conditions studied

- Head and Neck Squamous Cell Carcinoma (HNSCC)

## Interventions

- **DRUG:** Lymphoseek

## Key facts

- **NCT ID:** NCT00911326
- **Lead sponsor:** Navidea Biopharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-05
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 101 (ACTUAL)
- **Why stopped:** The trial was terminated early based on an interim review by the Data and Safety Monitoring Committee for positive efficacy outcome and no safety concerns.
- **Last updated:** 2014-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00911326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00911326, "Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00911326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*